UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPLB
6876
NYLI MacKay Core Plus Bond ETF
CPLB
$376M
| $38.3K | ﹤0.01% |
+1,832
| New | +$37.9K |
|
|
THCP
6877
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
| $38.2K | ﹤0.01% |
+3,657
| New | +$38.5K |
|
6878
Lichen China
LICN
$19.6M
| $38.2K | ﹤0.01% |
+131
| New | +$33.6K |
|
|
SCPH
6879
DELISTED
scPharmaceuticals
SCPH
| $38.1K | ﹤0.01% |
8,770
-25,464
| -74% | -$112K |
|
|
FIEE
6880
FiEE Inc
FIEE
$28.1M
| $38.1K | ﹤0.01% |
11,774
+10,703
| +999% | +$42.3K |
|
|
COOT
6881
Australian Oilseeds Holdings
COOT
$11.9M
| $38K | ﹤0.01% |
39,226
+36,939
| +1,615% | +$43.2K |
|
|
MTR
6882
Mesa Royalty Trust
MTR
$5.33M
| $38K | ﹤0.01% |
4,313
+965
| +29% | +$9.07K |
|
6883
Motorcar Parts of America
MPAA
$257M
| $38K | ﹤0.01% |
6,165
+6,106
| +10,349% | +$35.1K |
|
6884
Inter&Co
INTR
$2.53B
| $37.8K | ﹤0.01% |
6,141
-14,850
| -71% | -$85.5K |
|
6885
Smith-Midland
SMID
$149M
| $37.6K | ﹤0.01% |
1,359
+705
| +108% | +$25.8K |
|
6886
American Well
AMWL
$220M
| $37.6K | ﹤0.01% |
5,789
-50,100
| -90% | -$504K |
|
6887
AN2 Therapeutics
ANTX
$219M
| $37.6K | ﹤0.01% |
17,483
-2,091
| -11% | -$4.98K |
|
6888
Farmmi Inc
FAMI
$5.94M
| $37.6K | ﹤0.01% |
4,891
+4,123
| +537% | +$39.5K |
|
6889
CVD Equipment Corp
CVV
$57.9M
| $37.5K | ﹤0.01% |
9,643
+9,043
| +1,507% | +$41.5K |
|
6890
United States 12 Month Oil Fund,
USL
$43.4M
| $37.5K | ﹤0.01% |
925
-2,941
| -76% | -$117K |
|
6891
Crown Crafts
CRWS
$32.3M
| $37.4K | ﹤0.01% |
7,149
-213
| -3% | -$1.09K |
|
6892
ProShares Short Real Estate
REK
$11.8M
| $37.3K | ﹤0.01% |
1,976
+311
| +19% | +$6.07K |
|
6893
Nerdy
NRDY
$107M
| $37.3K | ﹤0.01% |
22,335
-94,180
| -81% | -$207K |
|
6894
Candel Therapeutics
CADL
$775M
| $37.2K | ﹤0.01% |
6,005
+5,995
| +59,950% | +$45K |
|
6895
Aclaris Therapeutics
ACRS
$851M
| $37.2K | ﹤0.01% |
33,791
-36,610
| -52% | -$43K |
|
6896
HF Foods Group
HFFG
$78.1M
| $37.1K | ﹤0.01% |
12,380
-28,212
| -70% | -$89.8K |
|
6897
ProShares UltraShort Health Care
RXD
$3.18M
| $37.1K | ﹤0.01% |
1,769
-401
| -18% | -$8.79K |
|
6898
FlexShares Credit-Scored US Long Corporate Bond Index Fund
LKOR
$30.2M
| $37.1K | ﹤0.01% |
+871
| New | +$37K |
|
|
CTNM
6899
Contineum Therapeutics
CTNM
$577M
| $37.1K | ﹤0.01% |
+2,107
| New | +$33.9K |
|
6900
Direct Digital Holdings
DRCT
$1.94M
| $37.1K | ﹤0.01% |
42
+3
| +8% | +$3.69K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.